⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21452947 | 1.00 | — | — | |
| SCHEMBL10062233 | 0.85 | MTNR1A (0.44) | — | |
| SCHEMBL14801544 | 0.81 | — | — | |
| SCHEMBL19442769 | 0.81 | — | — | |
| SCHEMBL29240481 | 0.81 | — | — | |
| SCHEMBL28518601 | 0.81 | — | — | |
| SCHEMBL19131288 | 0.80 | GABBR2 (0.39) | — | |
| SCHEMBL18085365 | 0.79 | PAOX (0.48) | — | |
| SCHEMBL14549906 | 0.78 | CACNA2D1 (0.35) | — | |
| SCHEMBL22273185 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357133-A1 | NANOMATERIALS COMPRISING CARBONATES | BEAM THERAPEUTICS INC. | 2023-11-09 | — | — | US | disclosed |
| EP-4262818-A1 | NANOMATERIALS COMPRISING CARBONATES | Beam Therapeutics Inc. (US) | 2023-10-25 | — | — | EP | disclosed |
| CN-116685332-A | Nanomaterial comprising carbonate | 比姆医疗股份有限公司 | 2023-09-01 | — | — | CN | disclosed |
| WO-2022140239-A1 | NANOMATERIALS COMPRISING CARBONATES | BEAM THERAPEUTICS INC. (US) | 2022-06-30 | — | — | WO | disclosed |
| WO-2019193516-A2 | SUBSTITUTED PYRIDINE AND PYRIMIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2019-10-10 | — | — | WO | disclosed |